Market Research Logo

Ferring International Center S.A. - Product Pipeline Review - 2016

Ferring International Center S.A. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Ferring International Center S.A. - Product Pipeline Review - 2016’, provides an overview of the Ferring International Center S.A.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ferring International Center S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Ferring International Center S.A.
The report provides overview of Ferring International Center S.A. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Ferring International Center S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Ferring International Center S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Ferring International Center S.A.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Ferring International Center S.A.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Ferring International Center S.A.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Ferring International Center S.A. Snapshot
Ferring International Center S.A. Overview
Key Information
Key Facts
Ferring International Center S.A. - Research and Development Overview
Key Therapeutic Areas
Ferring International Center S.A. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Ferring International Center S.A. - Pipeline Products Glance
Ferring International Center S.A. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Ferring International Center S.A. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Ferring International Center S.A. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Ferring International Center S.A. - Drug Profiles
follitropin delta
Product Description
Mechanism of Action
R&D Progress
Testavan
Product Description
Mechanism of Action
R&D Progress
degarelix acetate
Product Description
Mechanism of Action
R&D Progress
elobixibat
Product Description
Mechanism of Action
R&D Progress
selepressin
Product Description
Mechanism of Action
R&D Progress
barusiban
Product Description
Mechanism of Action
R&D Progress
carbetocin
Product Description
Mechanism of Action
R&D Progress
FE-999301
Product Description
Mechanism of Action
R&D Progress
merotocin
Product Description
Mechanism of Action
R&D Progress
FE-201874
Product Description
Mechanism of Action
R&D Progress
FE-204038
Product Description
Mechanism of Action
R&D Progress
FE-999310
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Ferring International Center S.A. - Pipeline Analysis
Ferring International Center S.A. - Pipeline Products by Target
Ferring International Center S.A. - Pipeline Products by Route of Administration
Ferring International Center S.A. - Pipeline Products by Molecule Type
Ferring International Center S.A. - Pipeline Products by Mechanism of Action
Ferring International Center S.A. - Recent Pipeline Updates
Ferring International Center S.A. - Dormant Projects
Ferring International Center S.A. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
DR-2011
Ferring International Center S.A. - Locations and Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Ferring International Center S.A., Key Information
Ferring International Center S.A., Key Facts
Ferring International Center S.A. - Pipeline by Indication, 2016
Ferring International Center S.A. - Pipeline by Stage of Development, 2016
Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016
Ferring International Center S.A. - Partnered Products in Pipeline, 2016
Ferring International Center S.A. - Partnered Products/ Combination Treatment Modalities, 2016
Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016
Ferring International Center S.A. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Ferring International Center S.A. - Pre-Registration, 2016
Ferring International Center S.A. - Phase III, 2016
Ferring International Center S.A. - Phase II, 2016
Ferring International Center S.A. - Preclinical, 2016
Ferring International Center S.A. - Pipeline by Target, 2016
Ferring International Center S.A. - Pipeline by Route of Administration, 2016
Ferring International Center S.A. - Pipeline by Molecule Type, 2016
Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016
Ferring International Center S.A. - Recent Pipeline Updates, 2016
Ferring International Center S.A. - Dormant Developmental Projects,2016
Ferring International Center S.A. - Discontinued Pipeline Products, 2016
Ferring International Center S.A., Other Locations
Ferring International Center S.A., Subsidiaries
List of Figures
Ferring International Center S.A. - Pipeline by Top 10 Indication, 2016
Ferring International Center S.A. - Pipeline by Stage of Development, 2016
Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016
Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016
Ferring International Center S.A. - Pipeline by Target, 2016
Ferring International Center S.A. - Pipeline by Route of Administration, 2016
Ferring International Center S.A. - Pipeline by Molecule Type, 2016
Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report